Life Sciences · Diagnostics
Diagnostics Contingent Workforce Solutions
Resource assay development, validation studies, laboratory operations, and regulatory documentation while the diagnostics rules keep moving.
Diagnostics contingent workforce solutions have to serve two operating rhythms at once. One is product development: assay design, analytical and clinical validation, and the regulatory documentation that follows. The other is the laboratory itself, where testing volume can move sharply and a staffing shortfall shows up in turnaround times the same week. Viltis builds programs that cover both, with qualification and access controls suited to laboratory and regulated environments instead of a generic staffing template dropped into a technical setting.
Overview
A regulatory picture that keeps moving
Diagnostics organizations have spent recent years absorbing overlapping regulatory change. The EU In Vitro Diagnostic Regulation reclassified a large share of assays into categories requiring notified body involvement for the first time, against constrained conformity assessment capacity. In the United States, the treatment of laboratory developed tests has been contested through rulemaking and litigation, and the position has continued to shift.
We do not advise on where that lands. What the workforce program gives you is the ability to add qualified regulatory, validation, and quality capacity quickly when the requirements change again, without carrying that capacity permanently against a scope nobody can pin down.
Overview
Product development resourcing
Assay development and validation work is project-shaped and specialization-heavy, which makes it a natural fit for contract resourcing when internal teams are committed to the current portfolio.
Assay development scientists across immunoassay, molecular, and sequencing-based platforms
Analytical validation specialists for precision, linearity, interference, and stability studies
Clinical validation study coordinators and data managers for method comparison studies
Biostatisticians for validation study design and analysis
Regulatory affairs specialists for IVDR technical documentation and premarket submissions
Software and bioinformatics specialists for algorithm-based and companion diagnostic products
Quality specialists for design control, risk management, and supplier quality
Overview
Laboratory operations capacity
Clinical laboratory staffing is a different problem with a different labor market. Medical technologists and laboratory scientists are in structural short supply in many regions, credentialing requirements are specific, and shift coverage is unforgiving. An unfilled position on a night shift is a turnaround time problem the same week.
The program treats credential verification, licensure tracking where it applies, competency assessment documentation, and shift-based scheduling as first-class requirements, not as adaptations of a professional staffing workflow.
Overview
Validation studies as a resourcing pattern
Clinical validation studies create an unusually clean contract labor profile: a defined enrollment period, a known specimen volume, a coordination and data management workload that ramps and then stops. Staffing them permanently is difficult to justify, and staffing them late delays the submission.
We resource studies to the protocol timeline, including the sample accessioning and data entry capacity that is routinely underestimated in study planning and then becomes the bottleneck.
Overview
Companion diagnostics and partnered programs
Companion diagnostic development ties your timeline to a pharmaceutical partner's clinical program, which means your resourcing has to follow their milestones as well as your own. Delays and accelerations both originate outside your organization.
A contingent-heavy model absorbs that volatility better than permanent hiring, and the program's reporting gives you a defensible basis for the cost conversations that partnered programs inevitably produce.
Benefits
What diagnostics organizations get
Regulatory capacity when rules shift
IVDR documentation and submission capacity can be added quickly when scope changes, without carrying specialists permanently against uncertain requirements.
Laboratory staffing handled properly
Credential verification, licensure tracking, competency documentation, and shift coverage are built into the workflow rather than bolted on.
Studies staffed to the protocol
Validation study coordination, accessioning, and data management ramp with enrollment and release at closeout, matching cost to activity.
Specialist platform expertise reachable
Supplier tiering preserves access to molecular, sequencing, and bioinformatics talent that generalist agencies rarely reach.
Partner-driven volatility absorbed
Companion diagnostic programs can flex with a pharmaceutical partner's timeline without permanent hiring decisions made on someone else's schedule.
Defensible cost reporting
Program analytics give you a clear basis for cost discussions in partnered and cost-shared development programs.
FAQ
Diagnostics contingent workforce FAQs
Can you staff CLIA-regulated laboratory roles?
Yes. Those roles carry specific personnel qualification requirements, and the program verifies credentials, education, and experience against the applicable requirements for the position before onboarding proceeds, retaining the documentation for inspection.
How do you handle licensure requirements that vary by state?
Licensure status is tracked as an onboarding requirement per assignment location, including expiry monitoring during the assignment. Where a location has its own personnel licensure regime, that is treated as a hard onboarding gate rather than a preference.
Do you support IVDR technical documentation work?
Yes, and it is one of the most common diagnostics requests we see: performance evaluation reports, technical documentation assembly, and post-market performance follow-up planning. Screening weights prior IVDR file experience specifically.
Can the program cover both R&D and clinical laboratory staffing?
Yes, though they are configured as distinct categories. They draw on different supplier bases, different screening standards, and different scheduling models, and treating them as one category tends to degrade both.
How do you resource a validation study with an uncertain start date?
By separating the sourcing from the engagement: candidates are identified and pre-screened, and assignments start when the protocol does. This shortens ramp-up without paying for capacity while the study is still awaiting approval.
Continue
Related industry programs
Ready to talk through your program?
Bring us your current spend, supplier list, and compliance obligations. We will show you what a technology-enabled contingent workforce program would look like for your organization.